LQDA

Liquidia Technologies Inc. is a pioneering biopharmaceutical company based in Morrisville, North Carolina, that leverages its proprietary PRINT technology to create innovative therapies for significant unmet medical needs. Specializing in precision manufacturing, Liquidia enhances targeted drug delivery and therapeutic efficacy, particularly addressing life-threatening conditions such as pulmonary hypertension. With a robust pipeline and a commitment to advancing patient outcomes through cutting-edge technology, Liquidia is strategically positioned for sustained growth in the rapidly evolving healthcare landscape.